These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 26213862)

  • 1. Association of clinical androgen excess with radial artery intima media thickness in women with polycystic ovary syndrome.
    Yilmaz SA; Kebapcilar A; Koplay M; Kerimoglu OS; Pekin AT; Gencoglu B; Dogan NU; Celik C
    Gynecol Endocrinol; 2015 Jun; 31(6):477-82. PubMed ID: 26213862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating levels of obestatin and copeptin in obese and nonobese women with polycystic ovary syndrome.
    Taskin MI; Bulbul E; Adali E; Hismiogulları AA; Inceboz U
    Eur J Obstet Gynecol Reprod Biol; 2015 Jun; 189():19-23. PubMed ID: 25837320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metastin levels in relation with hormonal and metabolic profile in patients with polycystic ovary syndrome.
    Yilmaz SA; Kerimoglu OS; Pekin AT; Incesu F; Dogan NU; Celik C; Unlu A
    Eur J Obstet Gynecol Reprod Biol; 2014 Sep; 180():56-60. PubMed ID: 25020276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-sensitivity C-reactive protein (hs-CRP) levels and its relationship with components of polycystic ovary syndrome in Indian adolescent women with polycystic ovary syndrome (PCOS).
    Ganie MA; Hassan S; Nisar S; Shamas N; Rashid A; Ahmed I; Douhat S; Mudassar S; Jan VM; Rashid F
    Gynecol Endocrinol; 2014 Nov; 30(11):781-4. PubMed ID: 25137507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlates of increased lean muscle mass in women with polycystic ovary syndrome.
    Carmina E; Guastella E; Longo RA; Rini GB; Lobo RA
    Eur J Endocrinol; 2009 Oct; 161(4):583-9. PubMed ID: 19605540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ultrasonographic and laboratory markers of metabolic and cardiovascular disease risk in obese women with polycystic ovary syndrome.
    Zueff LF; Martins WP; Vieira CS; Ferriani RA
    Ultrasound Obstet Gynecol; 2012 Mar; 39(3):341-7. PubMed ID: 21898634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The association of body mass index and biochemical hyperandrogenaemia in women with and without polycystic ovary syndrome.
    Yasmin E; Balen AH; Barth JH
    Eur J Obstet Gynecol Reprod Biol; 2013 Feb; 166(2):173-7. PubMed ID: 23102586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Serum levels of ghrelin and leptin in women with polycystic ovary syndrome].
    Pekhlivanov B; Mitkov M; Orbtsova M; Terzieva D
    Akush Ginekol (Sofiia); 2008; 47(3):15-9. PubMed ID: 18756827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum leptin levels correlate with clinical and biochemical indices of insulin resistance in women with polycystic ovary syndrome.
    Pehlivanov B; Mitkov M
    Eur J Contracept Reprod Health Care; 2009 Apr; 14(2):153-9. PubMed ID: 19340711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Exploration of the classification of polycystic ovarian syndrome].
    Lin JF; Li X; Zhu MW
    Zhonghua Fu Chan Ke Za Zhi; 2006 Oct; 41(10):684-8. PubMed ID: 17199924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Androgen levels in women with various forms of ovarian dysfunction: associations with cardiometabolic features.
    Daan NM; Jaspers L; Koster MP; Broekmans FJ; de Rijke YB; Franco OH; Laven JS; Kavousi M; Fauser BC
    Hum Reprod; 2015 Oct; 30(10):2376-86. PubMed ID: 26269538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered cortisol metabolism in polycystic ovary syndrome: insulin enhances 5alpha-reduction but not the elevated adrenal steroid production rates.
    Tsilchorozidou T; Honour JW; Conway GS
    J Clin Endocrinol Metab; 2003 Dec; 88(12):5907-13. PubMed ID: 14671189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Androgen excess is associated with the increased carotid intima-media thickness observed in young women with polycystic ovary syndrome.
    Luque-Ramírez M; Mendieta-Azcona C; Alvarez-Blasco F; Escobar-Morreale HF
    Hum Reprod; 2007 Dec; 22(12):3197-203. PubMed ID: 17933750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endocan is a predictor of increased cardiovascular risk in women with polycystic ovary syndrome.
    Bicer M; Guler A; Unal Kocabas G; Imamoglu C; Baloglu A; Bilgir O; Yuksel A; Bozkaya G; Calan M
    Endocr Res; 2017 May; 42(2):145-153. PubMed ID: 27911121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Left ventricular myocardial mass index and its correlates as an early marker of cardiovascular risk among nonobese normotensive Indian women with polycystic ovary syndrome: lessons from a cross-sectional study.
    Rashid A; Masood A; Wani IA; Hafeez I; Parvez T; Zagar MA; Ganie MA
    Fertil Steril; 2020 Jun; 113(6):1299-1307.e2. PubMed ID: 32482259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ultrasonographic evaluation of intra-abdominal fat distribution and study of its influence on subclinical atherosclerosis in women with polycystic ovarian syndrome.
    Tripathy P; Sahu A; Sahu M; Nagy A
    Eur J Obstet Gynecol Reprod Biol; 2017 Oct; 217():18-22. PubMed ID: 28850821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between androgen levels and blood pressure in young women with polycystic ovary syndrome.
    Chen MJ; Yang WS; Yang JH; Chen CL; Ho HN; Yang YS
    Hypertension; 2007 Jun; 49(6):1442-7. PubMed ID: 17389259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum ghrelin level in women with polycystic ovary syndrome and its relationship with endocrine and metabolic parameters.
    Mitkov M; Pehlivanov B; Orbetzova M
    Gynecol Endocrinol; 2008 Nov; 24(11):625-30. PubMed ID: 19031219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Free androgen index and Irisin in polycystic ovary syndrome.
    Li H; Xu X; Wang X; Liao X; Li L; Yang G; Gao L
    J Endocrinol Invest; 2016 May; 39(5):549-56. PubMed ID: 26584566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Body fat composition and distribution in women with polycystic ovary syndrome.
    Cosar E; Uçok K; Akgün L; Köken G; Sahin FK; Arioz DT; Baş O
    Gynecol Endocrinol; 2008 Aug; 24(8):428-32. PubMed ID: 18850379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.